Cargando…
PTEN and DNA Ploidy Status by Machine Learning in Prostate Cancer
SIMPLE SUMMARY: Molecular tissue-based prognostic biomarkers are anticipated to complement the current risk stratification systems in prostate cancer, but their manual assessment is subjective and time-consuming. Objective assessment of such biomarkers by machine learning-based methods could advance...
Autores principales: | Cyll, Karolina, Kleppe, Andreas, Kalsnes, Joakim, Vlatkovic, Ljiljana, Pradhan, Manohar, Kildal, Wanja, Tobin, Kari Anne R., Reine, Trine M., Wæhre, Håkon, Brennhovd, Bjørn, Askautrud, Hanne A., Skaaheim Haug, Erik, Hveem, Tarjei S., Danielsen, Håvard E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428363/ https://www.ncbi.nlm.nih.gov/pubmed/34503100 http://dx.doi.org/10.3390/cancers13174291 |
Ejemplares similares
-
Prognostic value of mitotic checkpoint protein BUB3, cyclin B1, and pituitary tumor-transforming 1 expression in prostate cancer
por: Ersvær, Elin, et al.
Publicado: (2019) -
Tumour heterogeneity poses a significant challenge to cancer biomarker research
por: Cyll, Karolina, et al.
Publicado: (2017) -
Chromatin organisation and cancer prognosis: a pan-cancer study
por: Kleppe, Andreas, et al.
Publicado: (2018) -
Cancer Prognosis Defined by the Combined Analysis of 8q, PTEN and ERG
por: Silva, Maria P., et al.
Publicado: (2016) -
Chromatin changes predict recurrence after radical prostatectomy
por: Hveem, Tarjei S, et al.
Publicado: (2016)